Dulcolax races to fight colon cancer
LONG BRANCH, N.J. — Temperatures eclipsed 90 degrees Fahrenheit for the second annual Jersey Shore Undy 5000 5-km race held here last month, where Team Dulcolax joined 665 people who turned out to support the colon cancer awareness-raising event. All told, participants generated more than $80,000 to help fight colon cancer.
A portion of the funds raised from the Jersey Shore Undy 5000 will be locally distributed to fund services for those diagnosed with colon cancer.
Boehringer Ingelheim, the maker of Dulcolax, is one of the chief sponsors of the 2011 Undy 5000 races — a series of 13 5-km run/walks in which participants are encouraged to wear boxer shorts to draw attention to the area of the body that is affected by colon cancer.
Hi-res imaging technology enables Rx verification
The National Association of Chain Drug Stores’ Pharmacy and Technology Conference in Boston will feature a multitude of suppliers showcasing everything from new drugs and devices to online services and pharmacy automation equipment. Among those suppliers is Innovation, which will display its latest machine for automating the counting and processing of medications, after having showed it at Cardinal Health’s Retail Business Conference in Las Vegas last month.
Innovation describes the PharmAssist OPTIx — part of its broader PharmAssist product line of pharmacy automation equipment — as countertop optical counting and imaging technology that is a “great fit” for any type of pharmacy, counting medicines in up to 200 milliseconds with an accuracy rate of 99.9%. “OPTIx combines tremendous counting speed and accuracy with high-resolution imaging and quality checks to enable pharmacies to increase throughput, provide the highest level of patient safety and perform remote prescription verification,” Innovation EVP global business development Doyle Jensen told Drug Store News. “Using OPTIx, pharmacies can employ lower-paid pharmacy techs to fill prescriptions, which frees up their pharmacists to perform other tasks and engage customers. After filling, techs can facilitate remote verification by using OPTIx to take a high-resolution image of each prescription’s vial contents and vial label.”
The device works by taking a high-resolution image of each prescription’s vial contents and label, and displaying them on a designated pharmacist’s workstation, thus enabling remote prescription verification — onsite or offsite — through comparison with images in a drug database.
Devices transform shelf
The expansion of intimacy health devices at mass is transforming the intimacy health segment into some pretty significant profit centers. “The total vibrations category currently has up to $1 billion in retail sales with no clear branded leader,” Church & Dwight’s CEO James Craigie told analysts earlier this month, noting that a line of full-sized personal massagers under the Trojan banner has launched through all classes of trade. “This is a category of new white space for our Trojan brand to enter,” he said.
Awareness around the availability of intimacy health devices within pharmacies is only going to get greater. New-to-mass LELO featured a high-end line of Kegel exercisers earlier this year at NACDS Marketplace — a product line that may represent the proverbial “next-step” in the evolution of intimacy health centers. The Laselle Kegel exercisers under the Intimina by LELO brand aren’t only a corrective solution for such conditions as incontinence; they’re also preventive.
The Laselle launch is expected to help drive awareness among women older than 55 years. And it’s that demographic that represents the strongest opportunity.
“The rise of sexually transmitted infections in that age group [both men and women] is growing disproportionate to the population,” noted Carol Carrozza, VP global marketing of sexual health and well-being at Ansell Healthcare Products. “It’s [a demographic] that we’re focusing on in our marketing efforts to provide education.”
The article above is part of the DSN Category Review Series. For the complete Intimacy Health Buy-In Report, including extensive charts, data and more analysis, click here.